Kelly E. Fisher

981 total citations
6 papers, 599 citations indexed

About

Kelly E. Fisher is a scholar working on Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Kelly E. Fisher has authored 6 papers receiving a total of 599 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Kelly E. Fisher's work include Cancer, Hypoxia, and Metabolism (2 papers), Melanoma and MAPK Pathways (2 papers) and Child Nutrition and Feeding Issues (1 paper). Kelly E. Fisher is often cited by papers focused on Cancer, Hypoxia, and Metabolism (2 papers), Melanoma and MAPK Pathways (2 papers) and Child Nutrition and Feeding Issues (1 paper). Kelly E. Fisher collaborates with scholars based in United States and China. Kelly E. Fisher's co-authors include Katherine G. Moss, Jingsong Yang, Roland S. Annan, Sylvie Laquerre, David Sutton, Arthur Groy, Aidan G. Gilmartin, Symon G. Erskine, Cynthia M. Rominger and Maureen R. Bleam and has published in prestigious journals such as Cancer Research, Biochemical Journal and Clinical Cancer Research.

In The Last Decade

Kelly E. Fisher

6 papers receiving 589 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kelly E. Fisher United States	4	434	288	91	87	80	6	599
Arthur Groy United States	6	497 1.1×	279 1.0×	109 1.2×	81 0.9×	78 1.0×	7	696
Eli Wallace United States	9	538 1.2×	296 1.0×	111 1.2×	53 0.6×	67 0.8×	16	697
Matthew Zubrowski United States	5	506 1.2×	266 0.9×	121 1.3×	76 0.9×	78 1.0×	6	624
Marian M. Deuker United States	6	580 1.3×	274 1.0×	118 1.3×	117 1.3×	88 1.1×	6	742
Yogindra Persaud United States	6	619 1.4×	368 1.3×	136 1.5×	105 1.2×	99 1.2×	12	818
T. Ahmad United Kingdom	7	566 1.3×	388 1.3×	78 0.9×	82 0.9×	56 0.7×	12	677
Wai Lin Wong United States	2	461 1.1×	324 1.1×	113 1.2×	80 0.9×	137 1.7×	4	681
Zoi Karoulia United States	6	560 1.3×	238 0.8×	130 1.4×	115 1.3×	58 0.7×	9	664
Chenjing Xia China	4	439 1.0×	308 1.1×	74 0.8×	70 0.8×	49 0.6×	9	538
Shivshankari Rajkumar Canada	5	310 0.7×	231 0.8×	123 1.4×	48 0.6×	82 1.0×	7	464

Countries citing papers authored by Kelly E. Fisher

Since Specialization

Citations

This map shows the geographic impact of Kelly E. Fisher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly E. Fisher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly E. Fisher more than expected).

Fields of papers citing papers by Kelly E. Fisher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly E. Fisher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly E. Fisher. The network helps show where Kelly E. Fisher may publish in the future.

Co-authorship network of co-authors of Kelly E. Fisher

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly E. Fisher. A scholar is included among the top collaborators of Kelly E. Fisher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly E. Fisher. Kelly E. Fisher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

Fisher, Kelly E., et al.. (2019). Elimination of Fermentable Carbohydrates to Reduce Gastrointestinal Symptoms in Pediatric Patients With Irritable Bowel Syndrome: A Narrative Review. Nutrition in Clinical Practice. 35(2). 231–245. 2 indexed citations

Isham, Crescent R., Vivian Negron, Kelly E. Fisher, et al.. (2013). Pazopanib Enhances Paclitaxel-Induced Mitotic Catastrophe in Anaplastic Thyroid Cancer. Science Translational Medicine. 5(166). 166ra3–166ra3. 58 indexed citations

Gilmartin, Aidan G., Maureen R. Bleam, Arthur Groy, et al.. (2011). GSK1120212 (JTP-74057) Is an Inhibitor of MEK Activity and Activation with Favorable Pharmacokinetic Properties for Sustained In Vivo Pathway Inhibition. Clinical Cancer Research. 17(5). 989–1000. 459 indexed citations

Pappalardi, Melissa B., Dean E. McNulty, John D. Martin, et al.. (2011). Biochemical characterization of human HIF hydroxylases using HIF protein substrates that contain all three hydroxylation sites. Biochemical Journal. 436(2). 363–369. 33 indexed citations

Rabindran, Sridhar K., Peter Sabbatini, Susan Korenchuk, et al.. (2009). Abstract #1740: Characterization of GSK1838705A, a small molecule inhibitor of the insulin-like growth factor-1 receptor and anaplastic lymphoma kinase that delays growth of IGF-1R-dependent tumors and causes regression of ALK-dependent tumors in vivo. Cancer Research. 69. 1740–1740. 2 indexed citations

Laquerre, Sylvie, Marc R. Arnone, Katherine G. Moss, et al.. (2009). Abstract B88: A selective Raf kinase inhibitor induces cell death and tumor regression of human cancer cell lines encoding B-RafV600E mutation. Molecular Cancer Therapeutics. 8(12_Supplement). B88–B88. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact